Cite

HARVARD Citation

    Lainez, N. et al. (2016). Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study. BMC cancer. 16 (1), pp. 1-10. [Online]. 
  
Back to record